Judes Poirier of Neuropsychopharmacology (CCNP). He was more recently awarded the Jonas Salk Award (1999) in honor of Dr. Salk, the inventor of the polio vaccine, the AstraZeneca/ASC/RxDx Award (2001) and the CSCC Award (2001) for his seminal work in the field of Alzheimer’s disease. In the summer of 2004, he was nominated to the rank of Knight of the National Order of Quebec by the Premier of Quebec. He received in the fall of 2009 a Doctorate Honoris Causa in Medicine in regard to his pioneering work in the field of Alzheimer’s research from this oldest School of Medicine in the
SAV001 a feasible option for an HIV vaccine. Indeed, Jonas Salk developed a therapeutic HIV vaccine in 1987, called Remune now being developed by Immune Response BioPharma, Inc., is based on the killed whole virus approach. Remune vaccine has completed over 25 clinical studies to date and showed a robust mechanism of action restoring white blood cell counts in CD4 & CD8 T cells by reducing viral load and increasing immunity. Also, a group of researchers and professionals in the field of HIV strongly advocates that the killed HIV approach must be taken to fight back the global HIV and AIDS